Whole Exome Sequencing of HCC1395 Tumor and Matched Normal HCC1395BL with Bulk RNA-seq of HCC1395
Whole Exome Sequencing (WES) was performed on the HCC1395 breast cancer cell line and its matched normal lymphoblastoid cell line HCC1395BL. Bulk RNA sequencing was performed on the HCC1395 tumor cell line. Libraries were sequenced using Illumina short-read technology (150 bp paired-end reads).Sequencing data were aligned to the human reference genome GRCh38 (hg38). The data were generated to support development of cancer neoantigen prediction pipelines, including pVACtools and ImmunoNX.The submitted files include aligned WES and RNA-seq data generated as part of the ImmunoNX workflow.